With Scalia’s Passing, Device Industry Loses Preemption Supporter On Supreme Court
This article was originally published in The Gray Sheet
Executive Summary
Justice Antonin Scalia’s death is not likely to have any immediate impact on the device industry – but at least one observer speculates that, down the road, more cases against manufacturers might be allowed to move forward in the lower courts despite preemption defense.
You may also be interested in...
Stryker-Zimmer Case Sets Up Tech Industry, Government Clash On Patent Damages Issue
In a case going before the Supreme Court in less than three weeks, Stryker is asking the court to broaden the circumstances under which patent damages may be tripled, a position the Obama administration appears to support but one that is getting pushback from tech firms, and at least one device-maker, Medtronic.
In Victory For Device Industry, Supreme Court Favors PMA Pre-emption
In a ruling that is expected to shave the volume of lawsuits against device manufacturers, the Supreme Court held that FDA premarket approval should preclude patients from suing companies for personal injury in most cases
SUPREME COURT MEDTRONIC V. LOHR RULING LEAVES POSSIBILITY OF TORT CLAIM PREEMPTION BY PMA REQUIREMENTS; PREEMPTION FOR 510(K) DEVICES ELIMINATED
The Supreme Court's ruling June 26 in the case of Medtronic v. Lohr includes opinions from five justices that leave open the possibility that premarket approval application requirements could preempt liability claims.